Human papillomavirus types 16 E6 and E7 contribute differently to carcinogenesis

Virology

Volumn 267, Issue 2, 2000, Pages 141-150

  Song, Shiyu ^a   Liem, Amy ^a   Miller, James A ^a   Lambert, Paul F ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN CARCINOGENESIS; SKIN TUMOR; UTERINE CERVIX CANCER; VIRUS CARCINOGENESIS; VIRUS GENE; WART VIRUS;

ANIMALIA; CANCER VIRUS; DNA VIRUSES; HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPES; MUS MUSCULUS; PAPILLOMAVIRUS; RNA VIRUSES;

EID: 0034652546     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1999.0106     Document Type: Article

References (64)

1. Arbeit J. M., Munger K., Howley P. M., Hanahan D. Neuroepithelial carcinomas in mice transgenic with human papillomavirus type 16 E6/E7 ORFs. Am. J. Pathol. 142:1993;1187-1197.
2. Baker C. C., Phelps W. C., Lindgren V., Braun M. J., Gonda M. A., Howley P. M. Structural and transcriptional analysis of human papillomavirus type 16 sequences in cervical carcinoma cell lines. J. Virol. 61:1987;962-971.
3. Ball N. J., Yohn J. J., Morelli J. G., Norris D. A., Golitz L. E., Hoeffler J. P. Ras mutations in human melanoma: A marker of malignant progression. J. Invest. Dermatol. 102:1994;285-290.
4. Boutwell R. K. Model systems for defining initiation, promotion, and progression of skin neoplasms. Prog. Clin. Biol. Res. 298:1989;3-15.
5. Brown K., Quintanilla M., Ramsden M., Kerr I. B., Young S., Balmain A. v-ras genes from Harvey and BALB murine sarcoma viruses can act as initiators of two-stage mouse skin carcinogenesis. Cell. 46:1986;447-456.
6. Chakravarti D., Pelling J. C., Cavalieri E. L., Rogan E. G. Relating aromatic hydrocarbon-induced DNA adducts and c-H-ras mutations in mouse skin papillomas: the role of apurinic sites. Proc. Natl. Acad. Sci. USA. 92:1995;10422-10426.
7. Chen J. J., Reid C. E., Band V., Androphy E. J. Interaction of papillomavirus E6 oncoproteins with a putative calcium-binding protein. Science. 269:1995;529-531.
8. Choo K. B., Pan C. C., Han S. H. Integration of human papillomavirus type 16 into cellular DNA of cervical carcinoma: preferential deletion of the E2 gene and invariable retention of the long control region and the E6/E7 open reading frames. Virology. 161:1987;259-261.
9. Cooper K., Herrington C. S., Lo E. S., Evans M. F., McGee J. O. Integration of human papillomavirus types 16 and 18 in cervical adenocarcinoma. J. Clin. Pathol. 45:1992;382-384.
10. Crook T., Storey A., Almond N., Osborn K., Crawford L. Human papillomavirus type 16 cooperates with activated ras and fos oncogenes in the hormone-dependent transformation of primary mouse cells. Proc. Natl. Acad. Sci. USA. 85:1988;8820-8824.
11. Dalal S., Gao Q., Androphy E. J., Band V. Mutational analysis of human papillomavirus type 16 E6 demonstrates that p53 degradation is necessary for immortalization of mammary epithelial cells. J. Virol. 70:1996;683-638.
12. Daling J. R., Sherman K. J., Hislop T. G., Maden C., Mandelson M. T., Beckmann A. M., Weiss N. S. Cigarette smoking and the risk of anogenital cancer. Am. J. Epidemiol. 135:1992;180-189.
13. Daniel B., Rangarajan A., Mukherjee G., Vallikad E., Krishna S. The link between integration and expression of human papillomavirus type 16 genomes and cellular changes in the evolution of cervical intraepithelial neoplastic lesions. J. Gen. Virol. 78:1997;1095-1101.
14. Drinkwater N. R. Experimental models and biological mechanisms for tumor promotion. Cancer Cells. 2:1990;8-15.
15. Dyson N., Guida P., Munger K., Harlow E. Homologous sequences in adenovirus E1A and human papillomavirus E7 proteins mediate interaction with the same set of cellular proteins. J. Virol. 66:1992;6893-6902.
16. Dyson N., Howley P. M., Munger K., Harlow E. The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science. 243:1989;934-937.
17. Gao Q., Srinivasan S., Boyer S. N., Wazer D. E., Band V. The E6 oncoprotein of high risk papillomaviruses bind to a novel putative GAP protein, E6TP1, and target it for degradation. Mol. Cell. Biol. 19:1999;733-744.
18. Greenhalgh D. A., Wang X. J., Rothnagel J. A., Eckhardt J. N., Quintanilla M. I., Barber J. L., Bundman D. S., Longley M. A., Schlegel R., Roop D. R. Transgenic mice expressing targeted HPV-18 E6 and E7 oncogenes in the epidermis develop verrucous lesions and spontaneous, rasHa-activated papillomas. Cell Growth Differ. 5:1994;667-675.
19. Griep A. E., Herber R., Jeon S., Lohse J. K., Dubielzig R. R., Lambert P. F. Tumorigenicity by human papillomavirus type 16 E6 and E7 in transgenic mice correlates with alterations in epithelial cell growth and differentiation. J. Virol. 67:1993;1373-1384.
20. Gulliver G., Herber R., Liem A., Lambert P. F. Both the CR1 and CR2 domains of HPV-16 E7 are required for the induction of epidermal hyperplasia and tumor formation in transgenic mice. J. Virol. 71:1997;5905-5914.
21. Herber R., Liem A., Pitot H., Lambert P. F. Squamous epithelial hyperplasia and carcinoma in mice transgenic for the human papillomavirus type 16 E7 oncogene. J. Virol. 70:1996;1873-1881.
22. Huibregtse J. M., Scheffner M., Howley P. M. A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18. EMBO J. 10:1991;4129-4135.
23. Iglesias M., Yen K., Gaiotti D., Hildesheim A., Stoler M. H., Woodworth C. D. Human papillomavirus type 16 E7 protein sensitizes cervical keratinocytes to apoptosis and release of interleukin-1alpha. Oncogene. 17:1998;1195-1205.
24. Imamoto A., Wang X. J., Fujiki H., Walker S. E., Beltran L. M., DiGiovanni J. Comparison of 12-O-tetradecanoylphorbol-13-acetate and teleocidin for induction of epidermal hyperplasia, activation of epidermal PKC isozymes and skin tumor promotion in SENCAR and C57BL/6 mice. Carcinogenesis. 14:1993;719-724.
25. Jones D. L., Thompson D. A., Munger K. Destabilization of the RB tumor suppressor protein and stabilization of p53 contribute to HPV type 16 E7-induced apoptosis. Virology. 239:1997;97-107.
26. Kalogeraki A., Tamiolakis D., Tzardi M., Datseris G., Karvelas K., Kanavaros P., Delides G. Cigarette smoking as a risk factor for intraepithelial lesion of the cervix uteri. In Vivo. 10:1996;613-616.
27. Kemp C. J., Donehower L. A., Bradley A., Balmain A. Reduction of p53 gene dosage does not increase initiation or promotion but enhances malignant progression of chemically induced skin tumors. Cell. 74:1993;813-822.
28. Kiyono T., Foster S. A., Koop J. I., McDougall J. K., Galloway D. A., Klingelhutz A. J. Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells [see comments]. Nature. 396:1998;84-88.
29. Kiyono T., Hiraiwa A., Fujita M., Hayashi Y., Akiyama T., Ishibashi M. Binding of high-risk human papillomavirus E6 oncoproteins to the human homologue of the Drosophila discs large tumor suppressor protein. Proc. Natl. Acad. Sci. USA. 94:1997;11612-11616.
30. Klingelhutz A. J., Foster S. A., McDougall J. K. Telomerase activation by the E6 gene product of human papillomavirus type 16. Nature. 380:1996;79-82.
31. Lambert P. F., Pan H., Pitot H. C., Liem A., Jackson M., Griep A. E. Epidermal cancer associated with expression of human papillomavirus type 16 E6 and E7 oncogenes in the skin of transgenic mice. Proc. Natl. Acad. Sci. USA. 90:1993;5583-5587.
32. Lee S. S., Weiss R. S., Javier R. T. Binding of human virus oncoproteins to hDlg/SAP97, a mammalian homolog of the Drosophila discs large tumor suppressor protein. Proc. Natl. Acad. Sci. USA. 94:1997;6670-6675.
33. Liu Z., Ghai J., Ostrow R. S., Faras A. J. The expression levels of the human papillomavirus type 16 E7 correlate with its transforming potential. Virology. 207:1995;260-270.
34. Liu Z., Ghai J., Ostrow R. S., McGlennen R. C., Faras A. J. The E6 gene of human papillomavirus type 16 is sufficient for transformation of baby rat kidney cells in cotransfection with activated Ha-ras. Virology. 201:1994;388-396.
35. McIntyre M. C., Ruesch M. N., Laimins L. A. Human papillomavirus E7 oncoproteins bind a single form of cyclin E in a complex with cdk2 and p107. Virology. 215:1996;73-82.
36. Munger K., Phelps W. C., Bubb V., Howley P. M., Schlegel R. The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes. J. Virol. 63:1989a;4417-4421.
37. Nakagawa S., Watanabe S., Yoshikawa H., Taketani Y., Yoshiike K., Kanda T. Mutational analysis of human papillomavirus type 16 E6 protein: transforming function for human cells and degradation of p53 in vitro. Virology. 212:1995;535-542.
38. Nakao Y., Yang X., Yokoyama M., Ferenczy A., Tang S. C., Pater M. M., Pater A. Induction of p16 during immortalization by HPV 16 and 18 and not during malignant transformation. Br. J. Cancer. 75:1997;1410-1416.
39. Ordman A. B., Cleaveland J. S., Boutwell R. K. 12-O-tetradecanoylphorbol-13-acetate promotes tumors prior to initiation in two-stage promotion. Cancer Lett. 29:1985;79-84.
40. Pan H., Griep A. E. Altered cell cycle regulation in the lens of HPV-16 E6 or E7 transgenic mice: implications for tumor suppressor gene function in development. Genes Dev. 8:1994;1285-1299.
41. Pan H., Griep A. E. Temporally distinct patterns of p53-dependent and p53-independent apoptosis during mouse lens development. Genes Dev. 9:1995;2157-2169.
42. Pence B. C., Reiners J. J. Jr. Murine epidermal xanthine oxidase activity: Correlation with degree of hyperplasia induced by tumor promoters. Cancer Res. 47:1987;6388-6392.
43. Phelps W. C., Yee C. L., Munger K., Howley P. M. The human papillomavirus type 16 E7 gene encodes transactivation and transformation functions similar to those of adenovirus E1A. Cell. 53:1988;539-547.
44. Prokopczyk B., Cox J. E., Hoffmann D., Waggoner S. E. Identification of tobacco-specific carcinogen in the cervical mucus of smokers and nonsmokers. J. Natl. Cancer Inst. 89:1997;868-873.
45. Quintanilla M., Brown K., Ramsden M., Balmain A. Carcinogen-specific mutation and amplification of Ha-ras during mouse skin carcinogenesis. Nature. 322:1986;78-80.
46. Reznikoff C. A., Belair C., Savelieva E., Zhai Y., Pfeifer K., Yeager T., Thompson K. J., DeVries S., Bindley C., Newton M. A. Long-term genome stability and minimal genotypic and phenotypic alterations in HPV16 E7-, but not E6-, immortalized human uroepithelial cells. Genes Dev. 8:1994;2227-2240.
47. Scheffner M., Huibregtse J. M., Vierstra R. D., Howley P. M. The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell. 75:1993;495-505.
48. Scheffner M., Werness B. A., Huibregtse J. M., Levine A. J., Howley P. M. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell. 63:1990;1129-1136.
49. Sherman L., Jackman A., Itzhaki H., Stoppler M. C., Koval D., Schlegel R. Inhibition of serum- and calcium-induced differentiation of human keratinocytes by HPV16 E6 oncoprotein: Role of p53 inactivation. Virology. 237:1997;296-306.
50. Sherman L., Schlegel R. Serum- and calcium-induced differentiation of human keratinocytes is inhibited by the E6 oncoprotein of human papillomavirus type 16. J. Virol. 70:1996;3269-3279.
51. Shin K. H., Min B. M., Cherrick H. M., Park N. H. Combined effects of human papillomavirus-18 and N-methyl-N′-nitro-N-nitrosoguanidine on the transformation of normal human oral keratinocytes. Mol. Carcinogen. 9:1994;76-86.
52. Snijders P. J., van Duin M., Walboomers J. M., Steenbergen R. D., Risse E. K., Helmerhorst T. J., Verheijen R. H., Meijer C. J. Telomerase activity exclusively in cervical carcinomas and a subset of cervical intraepithelial neoplasia grade III lesions: Strong association with elevated messenger RNA levels of its catalytic subunit and high-risk human papillomavirus DNA. Cancer Res. 58:1998;3812-3818.
53. Song S., Gulliver G. A., Lambert P. F. Human papillomavirus type 16 E6 and E7 oncogenes abrogate radiation-induced DNA damage responses in vivo through p53-dependent and p53-independent pathways. Proc. Natl. Acad. Sci. USA. 95:1998;2290-2295.
54. Song S., Pitot H. C., Lambert P. F. Human papillomavirus type 16 E6 gene alone is sufficient to induce carcinomas in transgenic animals. J. Virol. 73:1999;5887-5893.
55. Stoppler H., Stoppler M. C., Johnson E., Simbulan-Rosenthal C. M., Smulson M. E., Iyer S., Rosenthal D. S., Schlegel R. The E7 protein of human papillomavirus type 16 sensitizes primary human keratinocytes to apoptosis. Oncogene. 17:1998;1207-1214.
56. Storey A., Banks L. Human papillomavirus type 16 E6 gene cooperates with EJ-ras to immortalize primary mouse cells. Oncogene. 8:1993;919-924.
57. Tong X., Howley P. M. The bovine papillomavirus E6 oncoprotein interacts with paxillin and disrupts the actin cytoskeleton. Proc. Natl. Acad. Sci. USA. 94:1997;4412-4417.
58. Watanabe S., Kanda T., Sato H., Furuno A., Yoshiike K. Mutational analysis of human papillomavirus type 16 E7 functions. J. Virol. 64:1990;207-214.
59. Werness B. A., Levine A. J., Howley P. M. Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science. 248:1990;76-79.
60. White A. E., Livanos E. M., Tlsty T. D. Differential disruption of genomic integrity and cell cycle regulation in normal human fibroblasts by the HPV oncoproteins. Genes Dev. 8:1994;666-677.
61. Wright T. C., Kurman R. J., Ferenczy A. Precancerous lesions of the cervix. Kurman R. J. Blaustein's Pathology of the Female Genital Tract. 1994;229-277 Springer-Verlag, New York.
62. Zerfass K., Schulze A., Spitkovsky D., Friedman V., Henglein B., Jansen-Durr P. Sequential activation of cyclin E and cyclin A gene expression by human papillomavirus type 16 E7 through sequences necessary for transformation. J. Virol. 69:1995;6389-6399.
63. Zerfass-Thome K., Zwerschke W., Mannhardt B., Tindle R., Botz J. W., Jansen-Durr P. Inactivation of the cdk inhibitor p27KIP1 by the human papillomavirus type 16 E7 oncoprotein. Oncogene. 13:1996;2323-2330.
64. zur Hausen H. Papillomavirus infections-a major cause of human cancers. Biochim. Biophys. Acta. 1288:1996;F55-F78.